# Trade Mark Journal No.2025/033 15 August 2025

## UK00004245393 6 August 2025 (1,5,9,10,35,40,42)

SymphoRNA

Class 1
  Chemical substances and organic compounds for the manufacture of pharmaceuticals and dietary supplements; preservatives for use in the pharmaceutical and food industries; chemical substances and organic compounds for use in the biotechnology industry; chemical reagents for scientific and research use; nucleic acids, RNA, and mRNA for laboratory use; plasmids and gene vectors for research purposes; lipids and lipid-based substances for use in drug delivery systems; biologically active molecules for use in biotechnology; biochemical catalysts; culture media and reagents for growing cells and tissues in laboratory conditions; plant extracts for industrial and research use; vitamins, minerals, and proteins for use in food and supplement manufacture; Lipids and lipid-based formulations for industrial use in pharmaceutical and biotechnological manufacturing; fatty substances and carrier compounds for use in the production of therapeutic and nutritional products; lipid nanoparticles and other excipients for industrial use in drug delivery and supplement formulation.
Class 5
  Pharmaceutical preparations and substances; biological and biopharmaceutical preparations for medical and veterinary use; sanitary preparations for medical use; mRNA-based vaccines and therapeutics; RNA-based therapeutics, including small interfering RNA (siRNA), self-amplifying RNA (saRNA), microRNA (miRNA), guide RNA (gRNA), transfer RNA (tRNA), and circular RNA (circRNA); oligonucleotide-based therapeutics, including antisense oligonucleotides (ASOs), aptamers, and RNA interference (RNAi) agents; gene therapy preparations; CRISPR-based therapeutics and genome editing agents; immunotherapeutic agents; therapeutic preparations for modulation of immune responses; personalised medicine formulations; cell-based pharmaceutical preparations; in vivo cell therapy preparations in the form of pharmaceutical compositions; ex vivo cell therapy preparations in the form of pharmaceutical compositions comprising modified or unmodified cells for administration to patients; regenerative and tissue-based therapeutic products; pharmaceutical preparations incorporating lipid nanoparticles or other delivery systems; diagnostic reagents and test kits for medical use; veterinary preparations; dietetic food and substances adapted for medical or veterinary use; dietary supplements; nutritional supplements; protein, vitamin, and mineral supplements; herbal and plant-based supplements; food supplements for medical and non-medical use; dietary supplements for infants, children, and animals.
Class 9
  Downloadable software and mobile applications for use in the design, analysis, modelling, or optimisation of nucleic acid sequences, including RNA-based therapeutics; software for use in therapeutic delivery system design; software for bioinformatics, genetic analysis, and molecular diagnostics; downloadable databases and data management tools for drug discovery and personalised medicine; Downloadable machine learning software for identifying and predicting therapeutic targets, molecular interactions, or genetic biomarkers; downloadable artificial intelligence software for bioinformatics, genetic analysis, and drug discovery; software for use in pharmaceutical research, formulation design, and RNA delivery platform development.
Class 10
  Medical and diagnostic apparatus and instruments; injectors and drug delivery devices; wearable and implantable medical devices for administering pharmaceutical or gene therapy preparations; microneedle patches; transfection devices; medical diagnostic test kits for clinical and laboratory use; apparatus for RNA-based therapeutic delivery; devices for personalised medicine and genetic diagnostics; medical apparatus incorporating biosensors, nucleic acid detection systems, or AI-based diagnostic components; devices for nucleic acid transfection and RNA delivery.
Class 35
  Retail and wholesale services in connection with pharmaceuticals, biopharmaceuticals, dietary and nutritional supplements, medical devices, chemical substances and organic compounds for biotechnology and pharmaceutical use, laboratory reagents, diagnostic test kits, lipids and lipid-based formulations, plant-based supplements, vitamins, minerals, and other nutraceuticals; online retail services in the field of biotechnology, diagnostics, and healthcare products; retail services relating to RNA-based therapeutics, delivery systems, and oligonucleotide products.
Class 40
  Custom manufacture of pharmaceuticals, biopharmaceuticals, gene therapy products, dietary supplements, and therapeutic delivery systems; manufacturing of personalised medicine products; processing and synthesis of nucleic acids, including mRNA and DNA; production and purification of biological substances and reagents; formulation of lipid and polymer-based drug delivery systems; chemical or biological processing or transformation of organic substances, lipids, polymers, and excipients at the request of third parties; contract manufacturing of therapeutics, supplements, and RNA delivery platforms; production of synthetic genes, oligonucleotides, chemically modified RNAs, polymer conjugates, and lipid–polymer complexes.
Class 42
  Scientific and technological research in the fields of pharmaceuticals, biotechnology, and healthcare; pharmaceutical and biopharmaceutical research and development; development of mRNA-based therapeutics and vaccines; development of RNA-based therapeutics including siRNA, saRNA, and ASO platforms; genetic and molecular biology research; laboratory services; laboratory testing and analysis; bioinformatics and computational biology; AI-based drug discovery services; genetic profiling for therapeutic purposes; design and testing of drug delivery systems and personalised medicine platforms; industrial research and quality control services; technological consultancy in complex scientific fields; consultancy relating to biotechnology and pharmaceutical development; research and development of dietary supplements and nutraceuticals; software as a service (SaaS) and platform services for the design, modelling, or optimisation of RNA sequences, delivery technologies, and therapeutic formulations.

UNCOMMON BIO LIMITED